9 METERS BIOPHARMA, INC. (NMTR) has 30 open-market insider trades by 6 insiders since 2020. The most active filer is Mark A. Sirgo, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| OrbiMed Israel BioFund GP Limited Partnership via Erez Chimovits | 10% Owner | — | 1 | $40.7M | 2021-06-25 |
| Mark A. Sirgo | Dir | — | 11 | $1.4M | 2023-03-29 |
| John Temperato | CEO | — | 10 | $616K | 2023-03-27 |
| Edward J. Sitar | CFO | — | 3 | $108K | 2021-09-14 |
| Michael T. Constantino | Dir | — | 4 | $74K | 2023-03-29 |
| Bethany Sensenig | CFO | — | 1 | $11K | 2023-04-21 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Bethany Sensenig | CFO | Sell | $11K | 2023-04-21 |
| John Temperato | CEO | Buy | $29K | 2022-07-06 |
| Michael T. Constantino | Director | Buy | $8K | 2022-05-23 |
| Mark A. Sirgo | Director | Buy | $100K | 2022-05-18 |
| John Temperato | CEO | Buy | $23K | 2022-05-18 |
| John Temperato | CEO | Buy | $112K | 2022-03-03 |
Companies that share insiders with NMTR, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Mark A. Sirgo | Director | Buy | $100K | 2022-03-03 |
| Mark A. Sirgo | Director | Buy | $45K | 2021-12-02 |
| Mark A. Sirgo | Director | Buy | $21K | 2021-11-18 |
| John Temperato | CEO | Buy | $53K | 2021-11-18 |
| Edward J. Sitar | CFO | Buy | $18K | 2021-09-14 |
| Mark A. Sirgo | Director | Buy | $200K | 2021-09-07 |
| Michael T. Constantino | Director | Buy | $21K | 2021-08-24 |
| Mark A. Sirgo | Director | Buy | $28K | 2021-08-20 |
| John Temperato | CEO | Buy | $26K | 2021-08-18 |